| Dr Lisa Marie Lindsay Snow, DO | |
|
Schneck Pediatrics, 411 West Tipton Street, Seymour, IN 47274 | |
| (812) 523-7466 | |
| (812) 523-7471 |
| Full Name | Dr Lisa Marie Lindsay Snow |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | Schneck Pediatrics, Seymour, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922349596 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 02006011A (Indiana) | Primary |
| Entity Name | Jackson County Schneck Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629143037 PECOS PAC ID: 8224004585 Enrollment ID: O20041029000584 |
News Archive
The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy.
Genzyme Corporation announced today that it has entered into an agreement with Goldman, Sachs & Co. to repurchase $1 billion of Genzyme common stock under an accelerated stock repurchase program. Proceeds from its recently concluded debt offering will be used to support this first tranche of Genzyme's overall $2 billion share repurchase plan announced in May.
One of the biggest marketing trends in the online shopping industry is personalization through curated product recommendations; however, it can change whether people buy a product they had been considering, according to new University of California San Diego research.
Scientists from Harvard Medical School and MIT have designed a tattoo ink that can monitor a person's health by changing color to indicate dehydration or an increased blood sugar level, for example.
Working with human neurons and fruit flies, researchers at Johns Hopkins have identified and then shut down a biological process that appears to trigger a particular form of Parkinson's disease present in a large number of patients. A report on the study, in the April 10 issue of the journal Cell, could lead to new treatments for this disorder.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lisa Marie Lindsay Snow, DO 411 W Tipton St, Seymour, IN 47274-2363 Ph: (812) 523-7466 | Dr Lisa Marie Lindsay Snow, DO Schneck Pediatrics, 411 West Tipton Street, Seymour, IN 47274 Ph: (812) 523-7466 |
News Archive
The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy.
Genzyme Corporation announced today that it has entered into an agreement with Goldman, Sachs & Co. to repurchase $1 billion of Genzyme common stock under an accelerated stock repurchase program. Proceeds from its recently concluded debt offering will be used to support this first tranche of Genzyme's overall $2 billion share repurchase plan announced in May.
One of the biggest marketing trends in the online shopping industry is personalization through curated product recommendations; however, it can change whether people buy a product they had been considering, according to new University of California San Diego research.
Scientists from Harvard Medical School and MIT have designed a tattoo ink that can monitor a person's health by changing color to indicate dehydration or an increased blood sugar level, for example.
Working with human neurons and fruit flies, researchers at Johns Hopkins have identified and then shut down a biological process that appears to trigger a particular form of Parkinson's disease present in a large number of patients. A report on the study, in the April 10 issue of the journal Cell, could lead to new treatments for this disorder.
› Verified 9 days ago
Dr. Joseph Edward Lamb, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-523-4818 Fax: 812-522-0579 | |
Dr. Courtney M Savilla, DO Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-523-4818 Fax: 812-522-0579 | |
Dr. Marion Huff, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-523-4818 Fax: 812-522-0579 | |
Dr. Kristin Renee Sanders, Pediatrics Medicare: Medicare Enrolled Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-523-7466 Fax: 812-523-7471 | |
Ahmad Soliman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 120 Saint Louis Ave, Seymour, IN 47274 Phone: 812-524-8388 Fax: 812-954-5021 | |
Dr. Jane A. Pardieck, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 113 N Chestnut St, Seymour, IN 47274 Phone: 812-524-8388 |